Clinical Trials Browser

Hematologic Neoplasms × brexucabtagene autoleucel × 90 days × Clear all

NCT05041309 2026-05-14

Long-term Follow-up Study for Participants of Kite-Sponsored Interventional Studies Treated With Gene-Modified Cells

Enrolling by invitation

Other hematologic neoplasm

Hematologic Neoplasms